Brief: Autolus Therapeutics Reports Third Quarter 2021 Financial Results And Operational Progress
03/11/2021 12:18
Nov 3 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND OPERATIONAL PROGRESS
* Q3 LOSS PER SHARE $0.47
Source text for Eikon: ID:nGNXbRW7t6
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants